Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) Rivastigmine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.